| 标题 |
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Meric-Bernstam F; Beeram M; Hamilton E; Oh DY; Hanna DL; et al 出版日期:2022/12/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)